View Article

Abstract

The traditional classification of neurotransmitters has significantly evolved from early binary distinctions to cover a complex spectrum of chemical messengers with various structural and functional properties. This review presents an integral taxonomic framework that integrates the chemical structure with functional diversity to better understand the intricate communication networks within the brain. We examine how the classic categories of amino acids, biogenic amines, neuropeptides, purines and gaseous neurotransmitters intersect with functional roles that include excitement, inhibition, modulation, neuroendocrine signalling and stress responses. The emerging image reveals a highly interconnected system in which individual neurotransmitters often fulfil multiple functions in different regions and brain contexts, challenging traditional binary classifications and supporting the need for more nuanced taxonomic approaches in contemporary neuroscience.

Keywords

Neurotransmitter classification, Taxonomic Framework, synaptic transmission, neuroendocrine signalling, neuroscience

Introduction

The human brain operates through a sophisticated chemical communication system that involves dozens of neurotransmitter molecules that facilitate the transfer of information among billions of neurons. Since the early identification of acetylcholine and the subsequent discovery of other chemical messengers, our understanding of the diversity and function of neurotransmitters has expanded dramatically. However, traditional classification systems, although fundamental, have become increasingly inappropriate to capture all the complexity of brain chemistry. The classic approaches to typically classified neurotransmitters based on the chemical structure or primary function, creating artificial limits that obscure multifaceted nature of neural signalling. The reality of the neurotransmitter function reveals a more complex image in which individual molecules can comply with multiple roles, display context dependent effects and participate in overlapping networks that defy simple categorization. This review proposes a modern taxonomic framework that recognizes both chemical diversity and the functional plasticity of neurotransmitters. When examining how structural characteristics are related to functional skills while recognizing nature that depends on the context of neuronal signage, we can develop a more comprehensive understanding of brain chemistry that best serves the investigation of contemporary neuroscience and clinical applications.

Fig. 1. Schematic Diagram of Neurotransmitter and their transmission

Source: https://qbi.uq.edu.au/brain/brain-functions/what-are-neurotransmitters

2. Chemical Structure as a Foundation for Classification

2.1 Amino Acid Neurotransmitters: The Fundamental Building Blocks [6]

Amino acid neurotransmitters represent the most abundant and fundamental category of chemical messengers in the brain. These simple molecular structures, derived from common metabolic pathways, serve as the primary mediators of fast synaptic transmission throughout the central nervous system. Glutamate stands as the primary excitatory neurotransmitter, participating in approximately 80% of excitatory synapses in the brain. Its ubiquitous presence and rapid kinetics make it essential for basic neural communication, learning processes, and synaptic plasticity. The related amino acid aspartate shares similar excitatory properties, though its distribution and physiological roles remain more limited and specialized. On the inhibitory side, GABA (γ-aminobutyric acid) serves as the brain's primary inhibitory neurotransmitter, counterbalancing glutamate's excitatory influence. GABA's widespread distribution and multiple receptor subtypes enable fine-tuned inhibitory control across diverse brain regions. Glycine, while structurally simpler, provides crucial inhibitory functions primarily in the spinal cord and brainstem, demonstrating how chemical simplicity can enable specialized regional functions. The amino acid category illustrates a fundamental principle of neurotransmitter organization: structural simplicity often correlates with functional universality. These molecules' metabolic accessibility and rapid synthesis capabilities make them ideal for the high-frequency, high-volume communication demands of basic neural processing.

2.2 Biogenic Amines: Structural Diversity Enabling Functional Specialization [7]

The biogenic amines represent a more chemically diverse group, subdivided into catecholamines, indoleamines, and imidazole amines. This chemical diversity reflects their evolutionary origins and specialized functions in complex behaviors and physiological regulation. Catecholamines, including dopamine, norepinephrine, and epinephrine, share a common synthetic pathway and structural features that enable their roles in reward processing, attention, and stress responses. Dopamine's unique position as both a neurotransmitter and precursor to other catecholamines exemplifies the interconnected nature of neurotransmitter systems. Its functions span from basic motor control to complex cognitive processes like executive function and reward learning. Norepinephrine bridges central and peripheral nervous systems, serving dual roles in brain arousal and peripheral stress responses. This dual functionality demonstrates how chemical structure can enable molecules to operate across different physiological contexts while maintaining consistent basic properties. The indoleamines, serotonin and melatonin, derive from tryptophan metabolism and exhibit distinct yet related functions. Serotonin's extensive receptor family and diverse effects on mood, sleep, and appetite regulation illustrate how a single molecular structure can generate functional diversity through receptor specialization. Melatonin's role in circadian regulation represents a specialized evolutionary adaptation of the indoleamine structure for temporal signaling. Histamine, as the sole imidazoleamine neurotransmitter, demonstrates how unique chemical structures can evolve specialized functions. Its roles in wakefulness and immune responses bridge nervous and immune systems, highlighting the integrative nature of neurotransmitter function.

2.3 Cholinergic System: Ancient Origins, Modern Complexity [8]

Acetylcholine's distinction as a separate chemical category reflects both its historical significance as the first identified neurotransmitter and its unique chemical properties. Unlike other neurotransmitters derived from amino acids, acetylcholine's ester structure and rapid hydrolysis by acetylcholinesterase enable precise temporal control of signalling. The cholinergic system's dual receptor families (nicotinic and muscarinic) demonstrate how a single neurotransmitter can generate functional diversity through receptor evolution. Nicotinic receptors enable fast excitatory transmission crucial for motor control and cognitive processing, while muscarinic receptors mediate slower, modulatory effects important for learning and memory consolidation.

2.4 Neuropeptides: Complexity through Size and Diversity [9]

Neuropeptides represent the most structurally diverse category of neurotransmitters, ranging from small peptides like endorphins to larger molecules like orexin. This structural diversity enables highly specialized functions that complement the broader actions of smaller neurotransmitters. The endorphin family demonstrates how peptide structure can evolve to interact with specific receptor systems for specialized functions like pain modulation and reward processing. Their opioid-like properties illustrate convergent evolution between endogenous neurotransmitters and plant-derived compounds. Neuropeptide Y exemplifies the integrative functions of peptide neurotransmitters, participating in appetite regulation, stress responses, and emotional processing. Its wide distribution and multiple receptor subtypes enable region-specific effects while maintaining systemic coordination. Social behavior neuropeptides like oxytocin and vasopressin demonstrate how subtle structural differences (differing by only two amino acids) can generate distinct yet related functions. Their roles in social bonding, reproduction, and fluid balance illustrate the evolutionary adaptation of peptide structures for complex behavioral regulation. The orexin/hypocretin system represents a more recently discovered neuropeptide family whose functions in sleep-wake regulation and appetite control demonstrate the ongoing expansion of our understanding of neuropeptide diversity and function.

2.5 Purines and Gaseous Neurotransmitters: Expanding Chemical Boundaries [10]

The inclusion of purines and gaseous molecules as neurotransmitters represents the expanding boundaries of neurotransmitter classification. ATP's dual role as an energy currency and signaling molecule demonstrates how metabolic molecules can evolve neurotransmitter functions. Adenosine's role in sleep promotion and neuroprotection illustrates how purine metabolism can generate specialized signaling functions. Gaseous neurotransmitters like nitric oxide, carbon monoxide, and hydrogen sulfide challenge traditional concepts of neurotransmitter storage and release. Their ability to diffuse freely through cell membranes enables novel signaling mechanisms that complement traditional synaptic transmission. These molecules' roles in vasodilation, synaptic plasticity, and neuroprotection demonstrate how chemical innovation continues to expand neurotransmitter functional diversity.

Table No. 1: Classification of Neurotransmitters Based on Chemical Structure and Functional Characteristics

Neurotransmitter Class

Representative Molecules

Chemical Characteristics

Primary Functions

Amino Acid Neurotransmitters

Glutamate, Aspartate, GABA, Glycine

Small, metabolically derived from standard amino acids; fast synthesis and release

Glutamate & Aspartate: Excitatory signaling, synaptic plasticity; GABA & Glycine: Inhibitory control

Biogenic Amines

Dopamine, Norepinephrine, Epinephrine, Serotonin, Melatonin, Histamine

Derived from aromatic amino acids (tyrosine, tryptophan, histidine); structurally diverse

Regulation of mood, cognition, arousal, circadian rhythms, and autonomic functions

Cholinergic

Acetylcholine

Ester molecule; unique non-amino acid structure; rapidly degraded by acetylcholinesterase

Fast synaptic transmission (nicotinic); modulation of memory and learning (muscarinic)

Neuropeptides

Endorphins, Neuropeptide Y, Oxytocin, Vasopressin, Orexin

Chains of amino acids; high structural variability and receptor specificity

Modulation of pain, stress, appetite, emotional responses, social bonding, and sleep-wake cycles

Purines

ATP, Adenosine

Nucleotides and nucleosides; involved in metabolism and signaling

Synaptic modulation, neuroprotection, regulation of sleep and arousal

Gaseous Neurotransmitters

Nitric oxide (NO), Carbon monoxide (CO), Hydrogen sulfide (H?S)

Small gaseous molecules; diffuse across membranes; not stored in vesicles

Vasodilation, synaptic plasticity, retrograde signaling, neuroprotection

 

Fig. 2. Chemical Structure of Glutamate         

Fig. 3. Chemical Structure of Aspartate

Fig. 4. Chemical Structure of GABA           

Fig. 5. Chemical Structure of Gycine

Fig. 6. Chemical Structure of Dopamine           

Fig. 7. Chemical Structure of Norepinephrine

Fig. 8. Chemical Structure of Epinephrine      

Fig. 9. Chemical Structure of Serotonin

Fig. 10. Chemical Structure of Melatonin         

Fig. 11. Chemical Structure of Acetylcholine

Fig. 12. Chemical Structure of Oxytocin          

Fig. 13. Chemical Structure of Histamine

3. Functional Classification: Beyond Simple Excitation and Inhibition

3.1 Redefining Excitatory and Inhibitory Functions [11]

Traditional functional classification relied heavily on the binary distinction between excitatory and inhibitory neurotransmitters. However, modern understanding reveals this categorization as overly simplistic, failing to capture the context-dependent nature of neurotransmitter effects. Glutamate, while universally recognized as excitatory, demonstrates how even primary excitatory neurotransmitters can exhibit complex, context-dependent effects. Through different receptor subtypes (AMPA, NMDA, kainate, and metabotropic), glutamate can mediate everything from fast excitatory transmission to long-term synaptic plasticity and even excitotoxic cell death. This functional diversity within a single neurotransmitter system exemplifies the limitations of simple excitatory classification. Similarly, GABA's classification as purely inhibitory obscures its complex developmental and regional variations. During early development, GABA can actually be excitatory due to different chloride gradients in immature neurons. Even in adult brains, GABA's effects can vary significantly based on receptor subtypes, cellular location, and network context. The concept of context-dependent function becomes even more apparent with neurotransmitters like serotonin, which can be excitatory, inhibitory, or modulatory depending on receptor subtype, brain region, and physiological state. This flexibility challenges rigid functional categories and supports more nuanced classification approaches.

3.2 Modulatory Functions: The Orchestra Conductors [12]

Modulatory neurotransmitters represent a functional category that transcends simple excitation-inhibition dichotomies. These systems typically operate through slower, more prolonged mechanisms that influence the excitability and responsiveness of neural circuits rather than directly driving action potential generation. Dopamine exemplifies modulatory function through its ability to influence reward processing, motor control, and cognitive function across different brain regions. In the striatum, dopamine modulates motor programs and habit formation. In the prefrontal cortex, it influences working memory and executive function. In the ventral tegmental area and nucleus accumbens, it mediates reward learning and motivation. This regional specificity combined with consistent modulatory mechanisms demonstrates how single neurotransmitters can serve multiple functions through distributed network effects. The acetylcholine system's modulatory functions in attention and learning illustrate how ancient neurotransmitter systems can evolve sophisticated regulatory roles. Cholinergic modulation of cortical circuits enhances signal-to-noise ratios and facilitates learning processes, demonstrating how modulatory systems can optimize neural network performance. Norepinephrine's modulatory role in arousal and attention represents another example of how biogenic amines can serve as network-wide regulatory systems. The locus coeruleus-norepinephrine system's ability to modulate cortical, limbic, and brainstem circuits enables coordinated responses to environmental demands and internal states.

3.3 Neuroendocrine Integration: Bridging Neural and Hormonal Systems [13]

The neuroendocrine functions of certain neurotransmitters illustrate the artificial nature of boundaries between neural and hormonal signalling systems. Molecules like oxytocin, vasopressin, and melatonin operate simultaneously as neurotransmitters within the brain and hormones in the periphery. Oxytocin's dual roles in neural circuits mediating social behaviour and as a peripheral hormone regulating childbirth and lactation demonstrate the evolutionary advantage of using single molecules for related functions across different physiological systems. This dual functionality challenges traditional boundaries between neurotransmitter and hormone classification. The orexin/hypocretin system exemplifies modern understanding of neuroendocrine integration. Originally discovered in the context of feeding behaviour, orexin neurons are now known to integrate multiple physiological signals including energy balance, circadian rhythms, and arousal states. This integration demonstrates how individual neurotransmitter systems can serve as nexus points connecting diverse physiological processes.

3.4 Pain and Stress Response Networks: Specialized Functional Integration [14, 15]

Pain and stress response systems illustrate how neurotransmitters can be classified based on their roles in specific physiological processes that require coordinated multi-system responses. The endorphin system's role in pain modulation demonstrates how neuropeptides can evolve to interact with specific receptor systems for specialized adaptive functions. Substance P's function in pain transmission represents the other side of nociceptive processing, illustrating how paired neurotransmitter systems can evolve complementary functions. The balance between substance P-mediated pain transmission and endorphin-mediated pain suppression demonstrates the sophisticated regulatory mechanisms that have evolved around critical survival functions. Neuropeptide Y's roles in stress resilience and appetite regulation during stress responses illustrate how single neurotransmitters can coordinate multiple aspects of adaptive responses. This integration across physiological systems demonstrates the evolutionary advantage of using versatile signaling molecules for complex behavioral and physiological coordination.

Table No.2: Functional Classification of Neurotransmitters beyond the Excitation-Inhibition Dichotomy

Functional Category

Representative Neurotransmitters

Primary Roles

Mechanistic Insights

Key Brain Regions Involved

1. Context-Dependent Excitation & Inhibition

Glutamate, GABA, Serotonin

Excitatory or inhibitory depending on receptor type and context

- Glutamate: Activates AMPA, NMDA, kainate, and metabotropic receptors; involved in fast transmission, plasticity, and excitotoxicity
- GABA: Inhibitory via GABA_A and GABA_B; excitatory during development due to chloride gradient
- Serotonin: Excitatory, inhibitory, or modulatory depending on 5-HT receptor subtypes

Cortex, hippocampus, spinal cord, brainstem, and limbic structures

2. Modulatory Neurotransmitters

Dopamine, Acetylcholine, Norepinephrine

Regulate neural circuit excitability, learning, attention, arousal

- Dopamine: Modulates reward, motor control, cognition (via D1/D2 receptors)
- Acetylcholine: Enhances cortical signal-to-noise ratio and learning
- Norepinephrine: Adjusts arousal and stress through widespread projections

Prefrontal cortex, striatum, nucleus accumbens, locus coeruleus

3. Neuroendocrine Integration

Oxytocin, Vasopressin, Melatonin, Orexin

Dual roles in CNS signaling and systemic hormonal regulation

- Oxytocin/Vasopressin: Neural roles in bonding/social behavior and hormonal roles in lactation/osmoregulation
- Melatonin: Circadian rhythm regulator via suprachiasmatic nucleus
- Orexin: Integrates feeding, sleep-wake cycles, and energy balance

Hypothalamus, pituitary axis, pineal gland, limbic system

4. Pain and Stress Regulation

Endorphins, Substance P, Neuropeptide Y

Coordinate adaptive responses to nociception and stress

- Endorphins: Bind μ-opioid receptors, producing analgesia and euphoria
- Substance P: Transmits pain signals through NK1 receptors
- Neuropeptide Y: Modulates stress resilience and appetite

Periaqueductal gray, spinal cord, amygdala, hypothalamus

4. Integration and Network Perspectives

4.1 Co-transmission and Neurotransmitter Multiplexing [16]

Modern neuroscience increasingly recognizes that most neurons release multiple neurotransmitters, a phenomenon known as co-transmission. This discovery fundamentally challenges traditional "one neuron, one neurotransmitter" thinking and reveals the sophisticated information processing capabilities of individual neurons. Co-transmission enables neurons to convey multiple types of information simultaneously through different temporal and spatial dynamics. Fast amino acid neurotransmitters can convey immediate information while co-released peptides provide longer-term modulatory effects. This multiplexing capability dramatically increases the information-carrying capacity of neural circuits. The functional implications of co-transmission extend beyond simple additive effects. Different neurotransmitters can interact synergistically or antagonistically at target neurons, enabling complex computational operations at the level of individual synapses. This complexity requires classification systems that can accommodate multi-dimensional signaling properties rather than simple categorical assignments.

4.2 Receptor Diversity and Functional Specificity [17, 18]

The relationship between neurotransmitters and their receptors represents another dimension requiring consideration in modern classification systems. Single neurotransmitters often interact with multiple receptor subtypes that can have dramatically different functional consequences. The serotonin system exemplifies this receptor-mediated functional diversity. With over 14 distinct receptor subtypes, serotonin can mediate excitatory, inhibitory, and modulatory effects depending on which receptors are activated. This receptor diversity enables a single neurotransmitter to serve multiple functions while maintaining chemical identity. Glutamate's interaction with ionotropic (AMPA, NMDA, kainate) and metabotropic receptors demonstrates how receptor diversity enables both fast synaptic transmission and slower modulatory effects. NMDA receptors' voltage-dependent properties and calcium permeability enable their specialized roles in synaptic plasticity, while AMPA receptors mediate fast excitatory transmission.

4.3 Developmental and Evolutionary Perspectives [19, 20]

Neurotransmitter classification must also consider developmental and evolutionary contexts that influence both chemical structure and functional roles. The evolutionary conservation of basic neurotransmitter systems across species suggests fundamental principles of neural signaling, while species-specific modifications reveal adaptive specializations. The development of neurotransmitter systems during brain maturation demonstrates how function can change dramatically while chemical identity remains constant. GABA's excitatory effects during early development illustrate how cellular context can override basic chemical properties, supporting more flexible classification approaches that consider developmental stage and cellular environment. Evolutionary perspectives reveal how neurotransmitter systems have been co-opted for new functions while retaining ancestral roles. The evolution of dopamine from basic motor control functions to complex cognitive and motivational roles illustrates how neurotransmitter systems can acquire new functions through receptor evolution and circuit modification.

5. Toward a Modern Taxonomic Framework

5.1 Multi-Dimensional Classification Principles [21, 22]

A modern taxonomic framework for neurotransmitters must accommodate multiple dimensions of classification simultaneously rather than forcing artificial choices between chemical or functional categorization. This multi-dimensional approach recognizes that chemical structure, functional role, receptor interactions, anatomical distribution, and developmental expression all contribute to defining neurotransmitter identity and function. Chemical structure remains fundamental as it determines basic molecular properties like synthesis, storage, release mechanisms, and metabolic fate. However, structure alone cannot predict function given the context-dependent nature of neurotransmitter effects and the diversity of receptor-mediated responses. Functional classification must evolve beyond simple excitatory-inhibitory dichotomies to encompass modulatory roles, temporal dynamics, network effects, and behavioural consequences. This expanded functional perspective better captures the computational roles of neurotransmitter systems in information processing and behavioural control.

5.2 Dynamic and Context-Dependent Classification [23]

Modern classification systems must acknowledge the dynamic, context-dependent nature of neurotransmitter function. Rather than static categorical assignments, neurotransmitters should be understood as having functional profiles that vary based on brain region, developmental stage, physiological state, and network context. This dynamic perspective requires classification systems that can accommodate functional plasticity while maintaining molecular identity. Serotonin remains chemically identical whether it's regulating mood in the limbic system, controlling gut motility in the periphery, or modulating sleep-wake cycles in the brainstem, yet its functional significance varies dramatically across these contexts.

5.3 Integration with Modern Neuroscience Technologies [24, 25]

Contemporary classification frameworks must integrate with modern neuroscience technologies that enable unprecedented resolution in studying neurotransmitter systems. Single-cell RNA sequencing reveals the molecular diversity of neurotransmitter expression patterns, while optogenetics and chemogenetics enable precise manipulation of specific neurotransmitter populations. These technological advances require classification systems that can accommodate newly discovered complexity while maintaining practical utility for research and clinical applications. The framework must be flexible enough to incorporate new discoveries while providing clear organizational principles for understanding neurotransmitter diversity and function.

6. Clinical and Therapeutic Implications

6.1 Precision Medicine and Neurotransmitter Diversity [26-28]

Understanding neurotransmitter diversity and functional complexity has direct implications for developing more precise therapeutic approaches to neurological and psychiatric disorders. Traditional pharmacological approaches often target broad neurotransmitter systems, leading to widespread effects that can include unwanted side effects alongside therapeutic benefits. Modern classification frameworks that acknowledge receptor subtype diversity, regional specificity, and functional context enable more targeted therapeutic strategies. Developing drugs that selectively target specific receptor subtypes or regional neurotransmitter populations could improve therapeutic efficacy while reducing side effects. The recognition of co-transmission and neurotransmitter network interactions also suggests that combination therapies targeting multiple neurotransmitter systems simultaneously might be more effective than single-target approaches for complex disorders involving multiple neurotransmitter systems.

6.2 Biomarker Development and Diagnostic Applications [29, 30]

Comprehensive understanding of neurotransmitter classification and function facilitates the development of better biomarkers for neurological and psychiatric disorders. By understanding the specific neurotransmitter alterations associated with different disease states, researchers can develop more sensitive and specific diagnostic tools. The context-dependent nature of neurotransmitter function also suggests that biomarker interpretation must consider individual differences in neurotransmitter system organization and function. Personalized medicine approaches may need to account for individual variations in neurotransmitter receptor expression, metabolic capacity, and network organization.

7. Future Directions

7.1 Emerging Neurotransmitter Candidates [31, 32]

The expansion of neurotransmitter classification continues with the discovery of new candidate molecules and signaling mechanisms. Recent research has identified additional gaseous neurotransmitters, novel neuropeptides, and unconventional signaling molecules that challenge traditional boundaries of neurotransmitter definition. The discovery of microRNA signaling in synaptic contexts suggests that the definition of neurotransmitter may need to expand beyond traditional chemical messengers to include regulatory molecules that influence gene expression and protein synthesis. These developments require flexible classification frameworks that can accommodate novel signaling mechanisms while maintaining organizational coherence.

7.2 Technological Integration and Systems Approaches [33]

Future developments in neurotransmitter classification will likely integrate increasingly sophisticated technological approaches including proteomics, metabolomics, and systems-level network analysis. These approaches enable understanding of neurotransmitter function at multiple scales simultaneously, from molecular interactions to network-level effects on behavior and cognition. The development of real-time neurotransmitter monitoring technologies may also enable dynamic classification approaches that capture temporal variations in neurotransmitter function and interactions. These technological advances will require classification frameworks that can accommodate temporal dynamics and multi-scale interactions.

7.3 Synthesis and Integration [34]

The modern taxonomic framework presented here represents an evolution from traditional categorical thinking toward more nuanced, multi-dimensional approaches that better capture the complexity of brain chemistry. By integrating chemical structure with functional diversity while acknowledging context-dependent effects and network interactions, this framework provides a more comprehensive foundation for understanding neurotransmitter organization and function. The key insight emerging from this analysis is that neurotransmitter classification must embrace complexity rather than seeking oversimplified categories. The brain's chemical communication system operates through sophisticated interactions between diverse molecular messengers that serve multiple functions across different contexts and timescales. This complexity, rather than being a limitation, represents the evolutionary sophistication that enables the remarkable computational and behavioral capabilities of the nervous system. Understanding and working with this complexity, rather than trying to reduce it to simple categories, will be essential for advancing both basic neuroscience research and clinical applications. The framework proposed here provides a foundation for integrating existing knowledge while remaining flexible enough to accommodate future discoveries and technological advances. As our understanding of neurotransmitter diversity and function continues to expand, classification systems must evolve to match the sophistication of the systems they attempt to organize and understand.

Table No. 3: Integrative and Functional Perspectives in Modern Neurotransmitter Classification

Section

Focus Area

Key Concepts and Insights

4. Integration and Network Perspectives

4.1 Co-Transmission and Multiplexing

- Neurons can release multiple neurotransmitters (co-transmission)
- Fast neurotransmitters (e.g., glutamate, GABA) offer immediate signaling
- Co-released neuropeptides provide prolonged modulatory influence
- Neurotransmitter multiplexing enhances information processing at synaptic level
- Co-acting messengers may have synergistic or opposing effects

4.2 Receptor Diversity and Specificity

- A single neurotransmitter can act on multiple receptor subtypes
- Functional outcomes depend on receptor type (e.g., excitatory or inhibitory)
- Example: Serotonin acts on 14+ receptor subtypes
- Glutamate activates both ionotropic (AMPA, NMDA, kainate) and metabotropic receptors
- Receptor variety allows diverse temporal and spatial signaling

4.3 Developmental and Evolutionary Context

- Neurotransmitter roles may shift during development (e.g., GABA is excitatory early on)
- Functional adaptations across species show both conservation and divergence
- Dopamine evolution: from motor control to cognition and motivation

5. Toward a Modern Taxonomic Framework

5.1 Multi-Dimensional Classification

- Framework should include chemical structure, function, receptor profile, regional expression, and development
- Functional classification must include modulatory and context-dependent roles

5.2 Dynamic Classification Systems

- Neurotransmitter function varies across brain regions, developmental stages, and physiological states
- Static labels fail to capture functional plasticity
- Serotonin illustrates how the same molecule serves different roles across systems

5.3 Technological Integration

- Emerging methods (e.g., scRNA-seq, optogenetics) reveal neurotransmitter heterogeneity
- Classification must be compatible with molecular, cellular, and circuit-level data
- Frameworks need to evolve with experimental discoveries

6. Clinical and Therapeutic Implications

6.1 Precision Medicine

- Receptor subtype and regional targeting can improve drug efficacy
- Understanding co-transmission enables multi-target therapies
- Avoids systemic side effects seen with traditional mono-target agents

6.2 Biomarkers and Diagnostics

- Classification supports development of disease-specific biomarkers
- Biomarker interpretation must account for individual variation in neurotransmitter systems
- Personalized diagnostics may enhance treatment of neuropsychiatric disorders

7. Future Directions

7.1 Emerging Candidates

- New signaling molecules (e.g., gaseous messengers, microRNAs) challenge classical definitions
- Neurotransmitters may include non-traditional modulators with regulatory roles

7.2 Systems and Temporal Integration

- Tools like metabolomics and proteomics enable network-level analyses
- Real-time neurotransmitter monitoring supports dynamic functional classification

7.3 Synthesis and Conceptual Integration

- Modern taxonomy should embrace complexity over reductionism
- Integration of molecular identity, context-dependent effects, and network dynamics is essential
- Future frameworks must be flexible, scalable, and functionally informative

CONCLUSIONS

The study of neurotransmitters has long relied on broad categorical distinctions, but contemporary neuroscience demands a more sophisticated framework that unites chemical architecture with functional specialization. This modern approach reveals that neurotransmitter systems are not merely isolated entities but interconnected networks shaped by evolutionary pressures and molecular innovation. At the core of this paradigm is the recognition that chemical structure fundamentally determines signalling properties—whether through the rapid excitatory action of glutamate, the modulatory precision of dopamine, or the diffuse influence of gaseous transmitters like nitric oxide. By systematically analyzing neurotransmitters across structural families—amino acids, biogenic amines, peptides, and unconventional messengers—we uncover how subtle molecular variations translate into vast functional diversity. For instance, minor modifications in peptide sequences (e.g., oxytocin versus vasopressin) produce entirely distinct behavioural effects, while conserved motifs in catecholamines allow for specialized receptor interactions. This structure-function taxonomy also highlights the evolutionary logic underlying neurotransmitter systems. Ancient molecules such as acetylcholine and GABA have been conserved across species, while newer additions like orexin reflect adaptive responses to complex physiological demands. The expansion from small-molecule transmitters to neuropeptides parallels the increasing sophistication of neural circuits, enabling fine-tuned regulation of behavior, metabolism, and cognition. Moreover, the discovery of non-classical neurotransmitters—purines and gaseous molecules—challenges traditional definitions and underscores the need for a flexible classification system that accommodates diverse signalling mechanisms. The implications of this integrated framework extend beyond theoretical refinement. Clinically, it offers a roadmap for targeted drug development, particularly in disorders where neurotransmitter imbalance is implicated (e.g., depression, Parkinson’s disease, or epilepsy). By focusing on receptor subtypes or synthetic pathways unique to specific neurotransmitter families, therapies can achieve greater precision. For example, modulating neuropeptide Y receptors could address both metabolic and anxiety-related symptoms, while drugs targeting purinergic signaling might improve neuroprotection in stroke. Additionally, this taxonomy provides a scaffold for understanding cross-system interactions, such as the gut-brain axis, where multiple neurotransmitter families coordinate bidirectional communication. Ultimately, this modern classification system bridges gaps between molecular biology, systems neuroscience, and translational medicine. It emphasizes that neurotransmitters cannot be fully understood in isolation; their roles are defined by structural heritage, functional adaptability, and contextual deployment within neural networks. As research continues to uncover novel signaling molecules and mechanisms, this dynamic taxonomy will prove indispensable for deciphering the brain’s chemical lexicon—and harnessing its potential for therapeutic breakthroughs.

REFERENCE

  1. Altamura, C., Maes, M., Dai, J., & Meltzer, H. Y. (1995). Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression. European Neuropsychopharmacology, 5(3), 71-75.
  2. Barker, J. L., & Nicoll, R. A. (1973). The pharmacology and ionic dependency of amino acid responses in the frog spinal cord. Journal of Physiology, 228(2), 259-277.
  3. Bear, M. F., Connors, B. W., & Paradiso, M. A. (2020). Neuroscience: Exploring the brain (4th ed.). Wolters Kluwer.
  4. Berger, M., Gray, J. A., & Roth, B. L. (2009). The expanded biology of serotonin. Annual Review of Medicine, 60, 355-366.
  5. Burnstock, G. (2007). Physiology and pathophysiology of purinergic neurotransmission. Physiological Reviews, 87(2), 659-797.
  6. Carlsson, A. (2001). A paradigm shift in brain research. Science, 294(5544), 1021-1024.
  7. Chergui, K., Charlety, P. J., Akaoka, H., Saunier, C. F., Brunet, J. L., Buda, M., ... & Chouvet, G. (1993). Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo. European Journal of Neuroscience, 5(2), 137-144.
  8. Dale, H. H. (1935). Pharmacology and nerve-endings. Proceedings of the Royal Society of Medicine, 28(3), 319-332.
  9. Dani, J. A., & Bertrand, D. (2007). Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annual Review of Pharmacology and Toxicology, 47, 699-729.
  10. Davies, P., & Maloney, A. J. F. (1976). Selective loss of central cholinergic neurons in Alzheimer's disease. The Lancet, 308(7992), 1403.
  11. Dawson, T. M., & Snyder, S. H. (1994). Gases as biological messengers: nitric oxide and carbon monoxide in the brain. Journal of Neuroscience, 14(9), 5147-5159.
  12. de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X., Foye, P. E., Danielson, P. E., ... & Sutcliffe, J. G. (1998). The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proceedings of the National Academy of Sciences, 95(1), 322-327.
  13. Dunlap, K., Luebke, J. I., & Turner, T. J. (1995). Exocytotic Ca2+ channels in mammalian central neurons. Trends in Neurosciences, 18(2), 89-98.
  14. Feldberg, W., & Vogt, M. (1948). Acetylcholine synthesis in different regions of the central nervous system. Journal of Physiology, 107(4), 372-381.
  15. Freund, T. F., & Buzsáki, G. (1996). Interneurons of the hippocampus. Hippocampus, 6(4), 347-470.
  16. Garthwaite, J. (2008). Concepts of neural nitric oxide-mediated transmission. European Journal of Neuroscience, 27(11), 2783-2802.
  17. Hökfelt, T., Broberger, C., Xu, Z. Q., Sergeyev, V., Ubink, R., & Diez, M. (2000). Neuropeptides—an overview. Neuropharmacology, 39(8), 1337-1356.
  18. Insel, T. R. (2010). The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior. Neuron, 65(6), 768-779.
  19. Jessell, T. M., & Kandel, E. R. (1993). Synaptic transmission: a bidirectional and self-modifiable form of cell-cell communication. Cell, 72(1), 1-30.
  20. Jones, B. E. (2003). Arousal systems. Frontiers in Bioscience, 8(4), s438-s451.
  21. Kandel, E. R., Schwartz, J. H., Jessell, T. M., Siegelbaum, S. A., & Hudspeth, A. J. (2013). Principles of neural science (5th ed.). McGraw-Hill Education.
  22. Kimura, M. (1995). Role of basal ganglia in behavioral learning. Neuroscience Research, 22(4), 353-358.
  23. Krnjevic, K. (1974). Chemical nature of synaptic transmission in vertebrates. Physiological Reviews, 54(2), 418-540.
  24. Lodge, D. (2009). The history of the pharmacology and cloning of ionotropic glutamate receptors and the development of idiosyncratic nomenclature. Neuropharmacology, 56(1), 6-21.
  25. McGeer, P. L., Eccles, J. C., & McGeer, E. G. (1987). Molecular neurobiology of the mammalian brain (2nd ed.). Plenum Press.
  26. Olsen, R. W., & Sieghart, W. (2008). International Union of Pharmacology. LXX. Subtypes of γ-aminobutyric acid A receptors: classification on the basis of subunit composition, pharmacology, and function. Pharmacological Reviews, 60(3), 243-260.
  27. Panksepp, J. (1998). Affective neuroscience: The foundations of human and animal emotions. Oxford University Press.
  28. Saper, C. B., Scammell, T. E., & Lu, J. (2005). Hypothalamic regulation of sleep and circadian rhythms. Nature, 437(7063), 1257-1263.
  29. Schultz, W. (2007). Multiple dopamine functions at different time courses. Annual Review of Neuroscience, 30, 259-288.
  30. Siegel, G. J., Agranoff, B. W., Albers, R. W., Fisher, S. K., & Uhler, M. D. (1999). Basic neurochemistry: Molecular, cellular and medical aspects (6th ed.). Lippincott-Raven.
  31. Squire, L. R., Bloom, F. E., Spitzer, N. C., du Lac, S., Ghosh, A., & Berg, D. (2012). Fundamental neuroscience (4th ed.). Academic Press.
  32. Sudhof, T. C. (2004). The synaptic vesicle cycle. Annual Review of Neuroscience, 27, 509-547.
  33. Uhl, G. R., Kuhar, M. J., & Snyder, S. H. (1977). Neurotensin: immunohistochemical localization in rat central nervous system. Proceedings of the National Academy of Sciences, 74(9), 4059-4063.
  34. Wang, R. (2002). Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? The FASEB Journal, 16(13), 1792-1798.
  35. Zigmond, M. J., Bloom, F. E., Landis, S. C., Roberts, J. L., & Squire, L. R. (1999). Fundamental neuroscience. Academic Press.

Reference

  1. Altamura, C., Maes, M., Dai, J., & Meltzer, H. Y. (1995). Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression. European Neuropsychopharmacology, 5(3), 71-75.
  2. Barker, J. L., & Nicoll, R. A. (1973). The pharmacology and ionic dependency of amino acid responses in the frog spinal cord. Journal of Physiology, 228(2), 259-277.
  3. Bear, M. F., Connors, B. W., & Paradiso, M. A. (2020). Neuroscience: Exploring the brain (4th ed.). Wolters Kluwer.
  4. Berger, M., Gray, J. A., & Roth, B. L. (2009). The expanded biology of serotonin. Annual Review of Medicine, 60, 355-366.
  5. Burnstock, G. (2007). Physiology and pathophysiology of purinergic neurotransmission. Physiological Reviews, 87(2), 659-797.
  6. Carlsson, A. (2001). A paradigm shift in brain research. Science, 294(5544), 1021-1024.
  7. Chergui, K., Charlety, P. J., Akaoka, H., Saunier, C. F., Brunet, J. L., Buda, M., ... & Chouvet, G. (1993). Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo. European Journal of Neuroscience, 5(2), 137-144.
  8. Dale, H. H. (1935). Pharmacology and nerve-endings. Proceedings of the Royal Society of Medicine, 28(3), 319-332.
  9. Dani, J. A., & Bertrand, D. (2007). Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annual Review of Pharmacology and Toxicology, 47, 699-729.
  10. Davies, P., & Maloney, A. J. F. (1976). Selective loss of central cholinergic neurons in Alzheimer's disease. The Lancet, 308(7992), 1403.
  11. Dawson, T. M., & Snyder, S. H. (1994). Gases as biological messengers: nitric oxide and carbon monoxide in the brain. Journal of Neuroscience, 14(9), 5147-5159.
  12. de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X., Foye, P. E., Danielson, P. E., ... & Sutcliffe, J. G. (1998). The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proceedings of the National Academy of Sciences, 95(1), 322-327.
  13. Dunlap, K., Luebke, J. I., & Turner, T. J. (1995). Exocytotic Ca2+ channels in mammalian central neurons. Trends in Neurosciences, 18(2), 89-98.
  14. Feldberg, W., & Vogt, M. (1948). Acetylcholine synthesis in different regions of the central nervous system. Journal of Physiology, 107(4), 372-381.
  15. Freund, T. F., & Buzsáki, G. (1996). Interneurons of the hippocampus. Hippocampus, 6(4), 347-470.
  16. Garthwaite, J. (2008). Concepts of neural nitric oxide-mediated transmission. European Journal of Neuroscience, 27(11), 2783-2802.
  17. Hökfelt, T., Broberger, C., Xu, Z. Q., Sergeyev, V., Ubink, R., & Diez, M. (2000). Neuropeptides—an overview. Neuropharmacology, 39(8), 1337-1356.
  18. Insel, T. R. (2010). The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior. Neuron, 65(6), 768-779.
  19. Jessell, T. M., & Kandel, E. R. (1993). Synaptic transmission: a bidirectional and self-modifiable form of cell-cell communication. Cell, 72(1), 1-30.
  20. Jones, B. E. (2003). Arousal systems. Frontiers in Bioscience, 8(4), s438-s451.
  21. Kandel, E. R., Schwartz, J. H., Jessell, T. M., Siegelbaum, S. A., & Hudspeth, A. J. (2013). Principles of neural science (5th ed.). McGraw-Hill Education.
  22. Kimura, M. (1995). Role of basal ganglia in behavioral learning. Neuroscience Research, 22(4), 353-358.
  23. Krnjevic, K. (1974). Chemical nature of synaptic transmission in vertebrates. Physiological Reviews, 54(2), 418-540.
  24. Lodge, D. (2009). The history of the pharmacology and cloning of ionotropic glutamate receptors and the development of idiosyncratic nomenclature. Neuropharmacology, 56(1), 6-21.
  25. McGeer, P. L., Eccles, J. C., & McGeer, E. G. (1987). Molecular neurobiology of the mammalian brain (2nd ed.). Plenum Press.
  26. Olsen, R. W., & Sieghart, W. (2008). International Union of Pharmacology. LXX. Subtypes of γ-aminobutyric acid A receptors: classification on the basis of subunit composition, pharmacology, and function. Pharmacological Reviews, 60(3), 243-260.
  27. Panksepp, J. (1998). Affective neuroscience: The foundations of human and animal emotions. Oxford University Press.
  28. Saper, C. B., Scammell, T. E., & Lu, J. (2005). Hypothalamic regulation of sleep and circadian rhythms. Nature, 437(7063), 1257-1263.
  29. Schultz, W. (2007). Multiple dopamine functions at different time courses. Annual Review of Neuroscience, 30, 259-288.
  30. Siegel, G. J., Agranoff, B. W., Albers, R. W., Fisher, S. K., & Uhler, M. D. (1999). Basic neurochemistry: Molecular, cellular and medical aspects (6th ed.). Lippincott-Raven.
  31. Squire, L. R., Bloom, F. E., Spitzer, N. C., du Lac, S., Ghosh, A., & Berg, D. (2012). Fundamental neuroscience (4th ed.). Academic Press.
  32. Sudhof, T. C. (2004). The synaptic vesicle cycle. Annual Review of Neuroscience, 27, 509-547.
  33. Uhl, G. R., Kuhar, M. J., & Snyder, S. H. (1977). Neurotensin: immunohistochemical localization in rat central nervous system. Proceedings of the National Academy of Sciences, 74(9), 4059-4063.
  34. Wang, R. (2002). Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? The FASEB Journal, 16(13), 1792-1798.
  35. Zigmond, M. J., Bloom, F. E., Landis, S. C., Roberts, J. L., & Squire, L. R. (1999). Fundamental neuroscience. Academic Press.

Photo
Arnab Roy
Corresponding author

Department of Pharmacy, Sai Nath University, Ranchi, Jharkhand-835219, India

Photo
Nisha Kumari
Co-author

Department of Pharmacy, Sai Nath University, Ranchi, Jharkhand-835219, India

Photo
Pratik Mondal
Co-author

Department of Pharmacy, Sai Nath University, Ranchi, Jharkhand-835219, India

Photo
Ravi Kumar
Co-author

Department of Pharmacy, Sai Nath University, Ranchi, Jharkhand-835219, India

Photo
Balraj Kumar
Co-author

Department of Pharmacy, Sai Nath University, Ranchi, Jharkhand-835219, India

Photo
Dheeraj Prasad
Co-author

Department of Pharmacy, Sai Nath University, Ranchi, Jharkhand-835219, India

Photo
Manish Kumar Chandravanshi
Co-author

Department of Pharmacy, Sai Nath University, Ranchi, Jharkhand-835219, India

Photo
Munna Kumar Sharma
Co-author

Department of Pharmacy, Sai Nath University, Ranchi, Jharkhand-835219, India

Photo
Raj Kumar Rajak
Co-author

Department of Pharmacy, Sai Nath University, Ranchi, Jharkhand-835219, India

Photo
Anuj Vishwakarma
Co-author

Department of Pharmacy, Sai Nath University, Ranchi, Jharkhand-835219, India

Photo
Adarsh Kumar Singh
Co-author

Department of Pharmacy, Sai Nath University, Ranchi, Jharkhand-835219, India

Photo
Basant Kumar Verma
Co-author

Department of Pharmacy, Sai Nath University, Ranchi, Jharkhand-835219, India

Photo
Pravin Kumar
Co-author

Department of Pharmacy, Sai Nath University, Ranchi, Jharkhand-835219, India

Photo
Kuldeep Kumar
Co-author

Department of Pharmacy, Sai Nath University, Ranchi, Jharkhand-835219, India

Photo
Jaybir Singh
Co-author

Department of Pharmacy, Sai Nath University, Ranchi, Jharkhand-835219, India

Photo
Chandra Shekhar Gope
Co-author

Department of Pharmacy, Sai Nath University, Ranchi, Jharkhand-835219, India

Photo
Khusboo Kumari
Co-author

Department of Pharmacy, Sai Nath University, Ranchi, Jharkhand-835219, India

Nisha Kumari, Pratik Mondal, Ravi Kumar, Balraj Kumar, Dheeraj Prasad, Manish Kumar Chandravanshi, Munna Kumar Sharma, Raj Kumar Rajak, Anuj Vishwakarma, Adarsh Kumar Singh, Basant Kumar Verma, Pravin Kumar, Kuldeep Kumar, Jaybir Singh, Chandra Shekhar Gope, Khusboo Kumari, Arnab Roy*, Beyond Classical Categories: A Modern Taxonomic Framework for Brain Neurotransmitters Based on Chemical Structure and Functional Diversity, Int. J. Sci. R. Tech., 2025, 2 (8), 01-13. https://doi.org/10.5281/zenodo.16668165

More related articles
Nanoherbals: A Modern Approach in Herbal Medicine...
Parth Khandelwal, Vikram Sarukh, Hrishikesh Bhakade, Huzaifa Pate...
Computer-Aided Drug Design in Modern Pharmaceutica...
Deep Jyoti Shah, Mahesh Kumar Yadav, Astha Topno, Shivam Kashyap,...
Modern Therapeutic Approach towards Schizophrenia:...
Deep Jyoti Shah, Mahesh Kumar Yadav, Pintu Kumar, Love Mahato, Ku...
Ketamine in Modern Medicine: Antidepressant Breakthrough, Anesthetic Staple, or ...
Rahul Chaudhari , Mohan Nikam, Krushna Bharwad, Onkar Khatode , Aniruddh Thorat , Pratik Bhabad , ...
Herbal Drugs in Cancer Treatment: Current Advances, Efficacy, And Future Prospec...
Khot Nikhil, Lohar Dayanand, Khamkar Sakshi, Lokare Sonakshi, Karande Sankalp, Torskar Sourabh, Jama...
Related Articles
Nodular Sclerosis Classical Hodgkin Lymphoma in a Young Adult: A Comprehensive C...
Saira Susan Thomas, Pallippat Thumban Kheif Mamu, Manjima Sunil, ...
Advancing the Radiopharmaceutical Revolution: Innovation, Challenges, and Expand...
Alok Kumar, Ankita Singh, Mahesh Kumar Yadav, Aryan Singh, Faizan Raza, Md Raja Ansari, Md Affan, Ra...
Beyond Alkylation – Cyclophosphamide’s Expanding Role in Cancer Therapy and ...
Mohalkar Krushna, Dr. Tarde Vijay, Dahatonde Abhijit, Munfan Sumit, ...
Nanoherbals: A Modern Approach in Herbal Medicine...
Parth Khandelwal, Vikram Sarukh, Hrishikesh Bhakade, Huzaifa Patel, Amol Jadhav, Sohail Shaikh, ...
More related articles
Nanoherbals: A Modern Approach in Herbal Medicine...
Parth Khandelwal, Vikram Sarukh, Hrishikesh Bhakade, Huzaifa Patel, Amol Jadhav, Sohail Shaikh, ...
Computer-Aided Drug Design in Modern Pharmaceutical Research: An In-Silico Persp...
Deep Jyoti Shah, Mahesh Kumar Yadav, Astha Topno, Shivam Kashyap, Jiten Goray, Ajay Kumar, Amisha Ku...
Modern Therapeutic Approach towards Schizophrenia: A Comprehensive Review of Con...
Deep Jyoti Shah, Mahesh Kumar Yadav, Pintu Kumar, Love Mahato, Kush Mahato, Dulari Majhi, Aditya Raj...
Nanoherbals: A Modern Approach in Herbal Medicine...
Parth Khandelwal, Vikram Sarukh, Hrishikesh Bhakade, Huzaifa Patel, Amol Jadhav, Sohail Shaikh, ...
Computer-Aided Drug Design in Modern Pharmaceutical Research: An In-Silico Persp...
Deep Jyoti Shah, Mahesh Kumar Yadav, Astha Topno, Shivam Kashyap, Jiten Goray, Ajay Kumar, Amisha Ku...
Modern Therapeutic Approach towards Schizophrenia: A Comprehensive Review of Con...
Deep Jyoti Shah, Mahesh Kumar Yadav, Pintu Kumar, Love Mahato, Kush Mahato, Dulari Majhi, Aditya Raj...